Login
- A -
Austria- B -
Belgium- D -
Denmark- F -
FinlandFrance
- G -
GermanyGreece
- I -
Ireland (Eire)Italy
- N -
NetherlandsNorway
- P -
Portugal- S -
SpainSweden
Switzerland
- U -
United Kingdom
Population (2004)
10.4m
GDP (2003)
€132.590bn
Health expenditure (2003 budget)
Health expenditure as proportion of GDP
Size of pharmaceutical market
Proportion of GDP spent on pharmaceuticals
Proportion of health expenditure spent on medicines (2003)
Pharmaceutical market growth rate (2004)
Local currency
Euro (€)
Summary: Portugal
Medicines in Portugal have traditionally been cheaper than the Western European average prices but in recent years the Health Ministry has taken measures in moving prices in line with inflation. Health expenditure as a percentage of GDP has increased dramatically and is amongst the highest in Europe. To curb spending on pharmaceuticals, the government has been implementing measures to increase the use of generic drugs. Overall it seems that government action is paying off as the level of market penetration of generics has increased considerably and the administration estimates it has saved over €70m.
Summary of report content
- Summary
- How is the healthcare system structured?
- What size is the pharmaceutical market?
- Are pharmaceuticals taxed?
- How are drug prices set?
- How are prices changed?
- How are drugs reimbursed?
- Is there a payback arrangement?
- Are hospital sales controlled?
- Are OTC prices regulated?
- How are pharmaceutical costs controlled?
- How are generic drugs priced?
- What are wholesale/pharmacy margins?
- Is parallel trade influential?
- What to look out for
- Glossary
- Useful Contacts
Your Basket
Your basket is currently empty.
Search News
News
17/02/2005
Consultancy commissioned to review reimbursement scheme
17/02/2005
Preliminary Draft of the new Medicines Act published
Related Items